Pharmacy benefit costs continue to rise year over year, driven by a variety of factors including novel treatments, consumer demand, and federal legislation. This report provides insights into pharmacy cost and utilization trends based on our analysis of the Milliman Consolidated Health Cost Guidelines Sources Database. In this report you’ll find insights on emerging pharmacy trends, including:

• Weight-loss drugs
• Antidiabetics
• Biosimilars
• Copay assistance
• Attention-deficit/hyperactivity disorder (ADHD)